0.4499
4.63%
0.0199
Finanzdaten der Sensei Biotherapeutics Inc-Aktie (SNSE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
7.22%
8.73
|
8.142 | 7.737 | 10.18 | 11.01 |
Interest Income/Expense |
9.68%
0.028
|
0.031 | 0.033 | 0.038 | 0.042 |
Operating Income/Loss |
7.22%
-8.73
|
-8.142 | -7.737 | -10.18 | -11.01 |
Income/Loss From Continuing Operations Before Tax |
53.81%
-7.992
|
-17.30 | -7.124 | -9.386 | -10.18 |
Income Tax Expense/Benefit |
100.00%
-
|
-9.89 | - | - | - |
Income/Loss From Continuing Operations After Tax |
7.80%
-7.992
|
-7.414 | -7.124 | -9.386 | -10.18 |
Net Income/Loss
|
7.80%
-7.992
|
-7.414 | -7.124 | -9.386 | -10.18 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,630%
25.05
|
-0.9899 | 25.51 | 30.51 | 30.87 |
Diluted Average Shares |
2,630%
25.05
|
-0.9899 | 25.51 | 30.51 | 30.87 |
Basic Earnings Per Share |
6.67%
-0.32
|
-0.30 | -0.28 | -0.31 | -0.33 |
Diluted Earnings Per Share |
6.67%
-0.32
|
-0.30 | -0.28 | -0.31 | -0.33 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):